超声衰减用于肝脏脂肪定量:AIUM-RSNA QIBA 脉冲回波定量超声倡议
非酒精性脂肪性肝病(NAFLD)全球患病率高达30%,评估肝脂肪含量对识别及随访NAFLD患者至关重要。美国超声医学研究所-RSNA定量影像生物标志物联盟脉冲回波定量超声倡议旨在制定并标准化采集协议、理解超声脂肪定量的混杂因素,探索的定量超声参数包括衰减、背散射系数和声速。本文综述了衰减成像用于脂肪定量的现状,并就检查操作和结果解读提供专家意见,同时概述了需进一步研究的超声衰减方法。
要点
- 肝脂肪定量对识别NAFLD患者及随访病情至关重要。
- 定量超声脂肪定量探索的参数包括衰减、背散射系数和声速。
- 本文就衰减成像的操作与解读提供专家意见,并指出需进一步研究的方法。
核心结论
- 本文综述了超声衰减成像用于肝脂肪定量的现状,并就检查操作和结果解读提供专家意见,同时概述了需进一步研究的超声衰减方法。
研究设计与样本
- 本文为美国超声医学研究所-RSNA定量影像生物标志物联盟脉冲回波定量超声倡议的综述,旨在制定并标准化采集协议、理解超声脂肪定量的混杂因素,探索的定量超声参数包括衰减、背散射系数和声速。
临床应用与阅片要点
- 本文就超声衰减成像用于脂肪定量的检查操作和结果解读提供专家意见。
局限性
- 本文概述了需进一步研究的超声衰减方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide, with an estimated prevalence of up to 30% in the general population and higher in people with type 2 diabetes. The assessment of liver fat content is essential to help identify patients with or who are at risk for NAFLD and to follow their disease over time. The American Institute of Ultrasound in Medicine-RSNA Quantitative Imaging Biomarkers Alliance Pulse-Echo Quantitative Ultrasound Initiative was formed to help develop and standardize acquisition protocols and to better understand confounding factors of US-based fat quantification. The three quantitative US parameters explored by the initiative are attenuation, backscatter coefficient, and speed of sound. The purpose of this review is to present the current state of attenuation imaging for fat quantification and to provide expert opinion on examination performance and interpretation. US attenuation methods that need further study are outlined.
引用
- Ferraioli, Kumar, Ozturk, et al. US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative. Radiology. 2022. PMID: 35076304. doi:10.1148/radiol.210736
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。